s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid has been researched along with mk 0591 in 1 studies
| Studies (s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid) | Trials (s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid) | Recent Studies (post-2010) (s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid) | Studies (mk 0591) | Trials (mk 0591) | Recent Studies (post-2010) (mk 0591) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 64 | 6 | 17 |
| Protein | Taxonomy | s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid (IC50) | mk 0591 (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 2.6029 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 4.0003 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.011 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.2503 | |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | 0.0086 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boros, V; Burghardt, JS; Morgan, CJ; Olson, DM | 1 |
1 other study(ies) available for s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid and mk 0591
| Article | Year |
|---|---|
Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
Topics: Acute Disease; Animals; Animals, Newborn; Arachidonate 5-Lipoxygenase; Body Weight; Female; Hyperoxia; In Vitro Techniques; Indoles; Leukotrienes; Lipoxygenase Inhibitors; Lung; Lung Injury; Male; Naphthaleneacetic Acids; Pulmonary Alveoli; Quinolines; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |